Development and validation of a direct LC-MS-MS method to determine the acrolein metabolite 3-HPMA in urine

Journal of Chromatographic Science

Volumn 48, Issue 3, 2010, Pages 194-199

  Yan, Weiying ^a   Byrd, Gary D ^b,c   Brown, Buddy G ^c   Borgerding, Michael F ^c  

^a WAKE FOREST BAPTIST HEALTH   (United States)

^b TARGACEPT INC   (United States)

^c R J REYNOLDS TOBACCO COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77949303157     PISSN: 00219665     EISSN: None     Source Type: Journal    
DOI: 10.1093/chromsci/48.3.194     Document Type: Article

References (24)

1. C.M. Kaye. Biosynthesis of mercapturic acids from allyl alcohol, allyl esters and acrolein. Biochem. J. 134: 1093-1101 (1973).
2. J.M. Patel, J.C. Wood and K.C. Leibman. The biotransformation of allyl alcohol and acrolein in rat liver and lung preparations. Drug Metab. Dispos. 8: 305-308 (1980).
3. R.A. Parent, D.E. Paust, M.K. Schrimpf, R.E. Talaat, R.A. Doane, H.E. Caravello, S.J. Lee and D.E. Sharp. Metabolism and distribution of [2,3-14C]acrolein in Sprague-Dawley rats. II. Identification of urinary and fecal metabolites. Toxicol. Sci. 43: 110-120 (1998).
4. R.O. Beauchamp, Jr., D.A. Andjelkovich, A.D. Kligerman, K.T. Morgan and H.D. Heck. A critical review of the literature on acrolein toxicity. Crit.Rev.Toxicol.14: 309-380 (1985).
5. S.G. Carmella, M. Chen, Y. Zhang, S. Zhang, D.K. Hatsukami and S.S. Hecht. Quantitation of acrolein-derived (3-hydroxypropyl)mercapturic acid in human urine by liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometry: effects of cigarette smoking. Chem. Res. Toxicol. 20: 986-990 (2007).
6. R. Talhout, A. Opperhuizen and J.G. van Amsterdam. Sugars as tobacco ingredient: Effects on mainstream smoke composition. Food Chem. Toxicol. 44: 1789-1798 (2006).
7. G. Shelar. Sugar/nicotine study. tobaccodocuments.org (1992)
8. E.L. Carmines and C.L. Gaworski. Toxicological evaluation of glycerin as a cigarette ingredient. Food Chem. Toxicol. 43: 1521-1539 (2005)
9. G. Scherer, M. Urban and G. Gilch. Biomarkers for the tobacco smoke-related exposure to acrolein. CORESTA, Kyoto, Japan 2004
10. S.S. Hecht. Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer. Carcinogenesis. 23: 907-922 (2002).
11. D.K. Hatsukami, N.L. Benowitz, S.I. Rennard, C. Oncken and S.S. Hecht. Biomarkers to assess the utility of potential reduced exposure tobacco products. Nicotine Tob. Res. 8: 600-622 (2006).
12. H.J. Roethig, S. Feng, Q. Liang, J. Liu, W.A. Rees and B.K. Zedler. A 12-month, randomized, controlled study to evaluate exposure and cardiovascular risk factors in adult smokers switching from conventional cigarettes to a second-generation electrically heated cigarette smoking system. J.Clin.Pharmacol.48: 580-591 (2008).
13. R. Sanduja, G.A. Ansari and P.J. Boor. 3-Hydroxypropylmercapturic acid: a biologic marker of exposure to allylic and related compounds. J. Appl. Toxicol. 9: 235-238 (1989).
14. P.M. Giles. The biosynthesis of 3-hydroxypropylmercapturic acid from cyclophosphamide. Xenobiotica. 9: 745-762 (1979).
15. G. Scherer, C. Conze, A.R. Tricker and F. Adlkofer. Uptakeof tobaccosmokeconstituents on exposure to environmental tobacco smoke (ETS). Clin. Investig. 70: 352-367 (1992).
16. W. Stanek, P. Krenmayr, G. Scherer and E.R. Schmid. Quantitative determination of N-acetyl(-L-)cysteinederivatives inhumanurinebytandemmass spectrometry. Biol Mass Spectrom. 22: 133-142 (1993).
17. T.J. Athersuch, H. Keun, H. Tang and J.K. Nicholson. Quantitativeurinalysis of the mercapturic acid conjugates of allyl formate using high-resolution NMR spectroscopy. J. Pharm. Biomed. Anal. 40: 410-416 (2006).
18. D.G. Mascher, H.J. Mascher, G. Scherer and E.R. Schmid. High-performance liquid chromatographic-tandem mass spectrometric determination of 3-hydrox-ypropylmercapturic acid in human urine. J. Chromatogr. B Biomed. Sci. Appl.750: 163-169 (2001).
19. H.J. Roethig, B.K. Zedler, R.D. Kinser, S. Feng, B.L. Nelson and Q. Liang. Short-term clinical exposure evaluation of a second-generation electrically heated cigarette smoking system. J. Clin. Pharmacol. 47: 518-530 (2007)
20. T. Schettgen, A. Musiol and T. Kraus. Simultaneous determination of mercapturic acids derived from ethylene oxide (HEMA), propylene oxide (2-HPMA), acrolein (3-HPMA), acrylamide (AAMA) and N,N-dimethylformamide (AMCC) in human urine using liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom. 22: 2629-2638 (2008).
21. FDA/CDER, Drug Information Branch(HFD-210). Guidance for Industry on Bioanalytical Methods Validation for Human Studies. Rockville, MD. May, 2001
22. J.A. Maclellan, R.J. Traub and D.R. Fisher. Performance testing of radiobioassay laboratories: invitromeasurements(urinalysis), final report. NTISdocument PNL-6490 UC-41 March 1988, pp. 8-9.
23. A.J. Alpert. Hydrophilic-interaction chromatography for the separation of peptides, nucleic acids and other polar compounds. J. Chromatogr. 499: 177-196 (1990).
24. C.T. Viswanathan, S. Bansal, B. Booth, A.J. DeStefano, M.J. Rose, J. Sailstad, V.P. Shah, J.P. Skelly, P.G. Swann and R. Weiner. Quantitative bioanalytical methods validation and implementation: Best practices for chromatographic and ligand binding assays. The AAPS Journal. 9: E30-E42 (2007).